Pancreatic cancer is characterized by early metastatic spread, but the process of tumor cell dissemination is largely unknown. In this study we show that the soluble protein pancreatic adenocarcinoma ...

Pancreatic cancer is a notorious disease with a poor prognosis and low survival rates, which is due to limited advances in understanding of the molecular mechanism and inadequate development of ...

SINGAPORE--(BUSINESS WIRE)--Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, has developed a first-in-class diagnostic kit for pancreatic cancer. Pancreatic cancer is a ...

Fredrik "roque" Honak and Mathias "pauf" Köhler have been added to the Team Orbit line-up, successfully completing their roster. Today, the organization has decided to complete the line-up with one of ...

A systemic review and meta-analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel in the neoadjuvant treatment of localized pancreatic cancer. This is an ASCO Meeting Abstract from the 2022 ASCO ...

A prospective, single-arm clinical study of icaritin in combination with gemcitabine and nab-pacitaxel in patients with advanced pancreatic ductal adenocarcinoma not received prior systemic therapy.

FlipSid3 Tactics have announced that they have recruited Mathias "Pauf" Köhler and Andreas "schneider" Lindberg for their Counter-Strike: Global Offensive roster. Earlier last week we reported that ...

SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Limited (PBP) specializing in the development of antibody therapeutics, announced that French National Agency for the Safety of Medicines and Health ...

SINGAPORE, June 30, 2020 / B3C newswire / -- Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...

Prestige BioPharma Group has appointed a new leader to head its newly established Innovative Drug Research Institute, signaling a full-scale leap toward becoming a global pharmaceutical and bio ...